Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
Authors
Keywords
-
Journal
Pharmaceutics
Volume 12, Issue 5, Pages 401
Publisher
MDPI AG
Online
2020-04-29
DOI
10.3390/pharmaceutics12050401
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel
- (2019) Valentina Coccè et al. Pharmaceutics
- Advances in therapeutic applications of extracellular vesicles
- (2019) Oscar P. B. Wiklander et al. Science Translational Medicine
- Systematic review of targeted extracellular vesicles for drug delivery – Considerations on methodological and biological heterogeneity
- (2019) Johann Mar Gudbergsson et al. JOURNAL OF CONTROLLED RELEASE
- Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy
- (2019) Shen Cheng et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells
- (2019) Catharina Melzer et al. Cancers
- Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
- (2019) Koji Nakamura et al. Cancers
- The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles
- (2019) Genevieve E. Melling et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Adipocytes promote ovarian cancer chemoresistance
- (2019) Jiang Yang et al. Scientific Reports
- Adipose-Derived Mesenchymal Stem Cells Enhance Ovarian Cancer Growth and Metastasis by Increasing Thymosin Beta 4X-Linked Expression
- (2019) Yijing Chu et al. Stem Cells International
- Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
- (2019) Aziz et al. Cancers
- Shedding light on the cell biology of extracellular vesicles
- (2018) Guillaume van Niel et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise
- (2018) Timothy E. G. Krueger et al. Stem Cells Translational Medicine
- Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
- (2018) Alia Ghoneum et al. Cancer Medicine
- Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
- (2018) Maureen L. Drakes et al. Cancers
- CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
- (2018) Naike Casagrande et al. HAEMATOLOGICA
- An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
- (2018) Takeshi Motohara et al. ONCOGENE
- FBXL7 Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer
- (2018) Hui-Wen Chiu et al. Journal of Clinical Medicine
- Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system
- (2017) Barbara Crivelli et al. JOURNAL OF CONTROLLED RELEASE
- Adipose Tissue-Derived Stromal Cells Primed in Vitro with Paclitaxel Acquire Anti-Tumor Activity
- (2017) A. Bonomi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Preclinical Activity of the Liposomal Cisplatin Lipoplatin in Ovarian Cancer
- (2014) N. Casagrande et al. CLINICAL CANCER RESEARCH
- Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery
- (2014) Luisa Pascucci et al. JOURNAL OF CONTROLLED RELEASE
- Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
- (2014) Q Cai et al. ONCOGENE
- Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer
- (2013) Naike Casagrande et al. GYNECOLOGIC ONCOLOGY
- A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro
- (2013) Janet Myungjin Lee et al. LABORATORY INVESTIGATION
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Modeling Colon Adenocarcinomas in Vitro
- (2011) Helmut Dolznig et al. AMERICAN JOURNAL OF PATHOLOGY
- Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy
- (2011) Augusto Pessina et al. PLoS One
- High-throughput plasma docetaxel quantification by liquid chromatography–tandem mass spectrometry
- (2010) Giuseppe Corona et al. CLINICA CHIMICA ACTA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now